{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:42:37Z","timestamp":1790631757043,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s12630-023-02520-4","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T21:01:43Z","timestamp":1687986103000},"page":"1381-1393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The perioperative use of inhaled prostacyclins in cardiac surgery: a systematic review and meta-analysis","Utilisation p\u00e9riop\u00e9ratoire de prostacyclines par inhalation en chirurgie cardiaque\u00a0: une revue syst\u00e9matique et m\u00e9ta-analyse"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5095-5815","authenticated-orcid":false,"given":"Berend","family":"Marcus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Marynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Fieuws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Van Beersel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Rega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Rex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"2520_CR1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/s1010-7940(99)00106-2","volume":"15","author":"F Roques","year":"1999","unstructured":"Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999; 15: 816\u201322. https:\/\/doi.org\/10.1016\/s1010-7940(99)00106-2","journal-title":"Eur J Cardiothorac Surg"},{"key":"2520_CR2","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/0003-4975(95)00526-q","volume":"60","author":"VG D\u00e1vila-Rom\u00e1n","year":"1995","unstructured":"D\u00e1vila-Rom\u00e1n VG, Waggoner AD, Hopkins WE, Barzilai B. Right ventricular dysfunction in low output syndrome after cardiac operations: assessment by transesophageal echocardiography. Ann Thorac Surg 1995; 60: 1081\u20136. https:\/\/doi.org\/10.1016\/0003-4975(95)00526-q","journal-title":"Ann Thorac Surg"},{"key":"2520_CR3","doi-asserted-by":"publisher","first-page":"667328","DOI":"10.3389\/fcvm.2021.667328","volume":"8","author":"D Levy","year":"2021","unstructured":"Levy D, Laghlam D, Estagnasie P, Brusset A, Squara P, Nguyen LS. Post-operative right ventricular failure after cardiac surgery: a cohort study. Front Cardiovasc Med 2021; 8: 667328. https:\/\/doi.org\/10.3389\/fcvm.2021.667328","journal-title":"Front Cardiovasc Med"},{"key":"2520_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/aca.aca_123_17","volume":"21","author":"MS Sarkar","year":"2018","unstructured":"Sarkar MS, Desai PM. Pulmonary hypertension and cardiac anesthesia: anesthesiologist's perspective. Ann Card Anaesth 2018; 21: 116\u201322. https:\/\/doi.org\/10.4103\/aca.aca_123_17","journal-title":"Ann Card Anaesth"},{"key":"2520_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/bf03007436","volume":"27","author":"JA Kaplan","year":"1980","unstructured":"Kaplan JA, Finlayson DC, Woodward S. Vasodilator therapy after cardiac surgery: a review of the efficacy and toxicity of nitroglycerin and nitroprusside. Can Anaesth Soc J 1980; 27: 254\u20139. https:\/\/doi.org\/10.1007\/bf03007436","journal-title":"Can Anaesth Soc J"},{"key":"2520_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1183\/09031936.00124007","volume":"32","author":"MR Wilkins","year":"2008","unstructured":"Wilkins MR, Wharton J, Grimminger F, Ghofrani HA. Phosphodiesterase inhibitors for the treatment of pulmonary hypertension. Eur Respir J 2008; 32: 198\u2013209. https:\/\/doi.org\/10.1183\/09031936.00124007","journal-title":"Eur Respir J"},{"key":"2520_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/0971-9784.62946","volume":"13","author":"B Mandal","year":"2010","unstructured":"Mandal B, Kapoor PM, Chowdhury U, Kiran U, Choudhury M. Acute hemodynamic effects of inhaled nitroglycerine, intravenous nitroglycerine, and their combination with intravenous dobutamine in patients with secondary pulmonary hypertension. Ann Card Anaesth 2010; 13: 138\u201344. https:\/\/doi.org\/10.4103\/0971-9784.62946","journal-title":"Ann Card Anaesth"},{"key":"2520_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/nejmoa020204","volume":"347","author":"H Olschewski","year":"2002","unstructured":"Olschewski H, Simonneau G, Gali\u00e8 N, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002; 347: 322\u20139. https:\/\/doi.org\/10.1056\/nejmoa020204","journal-title":"N Engl J Med"},{"key":"2520_CR9","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1053\/j.jvca.2017.12.014","volume":"32","author":"V Rao","year":"2018","unstructured":"Rao V, Ghadimi K, Keeyapaj W, Parsons CA, Cheung AT. Inhaled nitric oxide (iNO) and inhaled epoprostenol (iPGI2) use in cardiothoracic surgical patients: is there sufficient evidence for evidence-based recommendations? J Cardiothorac Vasc Anesth 2018; 32: 1452\u20137. https:\/\/doi.org\/10.1053\/j.jvca.2017.12.014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2520_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000313863","volume":"116","author":"M Winterhalter","year":"2010","unstructured":"Winterhalter M, Antoniou T, Loukanov T. Management of adult patients with perioperative pulmonary hypertension: technical aspects and therapeutic options. Cardiology 2010; 116: 3\u20139. https:\/\/doi.org\/10.1159\/000313863","journal-title":"Cardiology"},{"key":"2520_CR11","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/s0022-5223(03)00704-9","volume":"126","author":"F Langer","year":"2003","unstructured":"Langer F, Wilhelm W, Tscholl D, et al. Intraoperative inhalation of the long-acting prostacyclin analog iloprost for pulmonary hypertension. J Thorac Cardiovasc Surg 2003; 126: 874\u20135. https:\/\/doi.org\/10.1016\/s0022-5223(03)00704-9","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2520_CR12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/00000542-200309000-00033","volume":"99","author":"S Rex","year":"2003","unstructured":"Rex S, Busch T, Vettelschoss M, de Rossi L, Rossaint R, Buhre W. Intraoperative management of severe pulmonary hypertension during cardiac surgery with inhaled iloprost. Anesthesiology 2003; 99: 745\u20137. https:\/\/doi.org\/10.1097\/00000542-200309000-00033","journal-title":"Anesthesiology"},{"key":"2520_CR13","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1097\/00003246-200212000-00023","volume":"30","author":"SM Lowson","year":"2002","unstructured":"Lowson SM, Doctor A, Walsh BK, Doorley PA. Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery. Crit Care Med 2002; 30: 2762\u20134. https:\/\/doi.org\/10.1097\/00003246-200212000-00023","journal-title":"Crit Care Med"},{"key":"2520_CR14","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700. https:\/\/doi.org\/10.1136\/bmj.b2700","journal-title":"BMJ"},{"key":"2520_CR15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1177\/0310057x0903700314","volume":"37","author":"P Forrest","year":"2009","unstructured":"Forrest P. Anaesthesia and right ventricular failure. Anaesth Intensive Care 2009; 37: 370\u201385. https:\/\/doi.org\/10.1177\/0310057x0903700314","journal-title":"Anaesth Intensive Care"},{"key":"2520_CR16","doi-asserted-by":"publisher","first-page":"e578","DOI":"10.1161\/cir.0000000000000560","volume":"137","author":"MA Konstam","year":"2018","unstructured":"Konstam MA, Kiernan MS, Bernstein D, et al. Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association. Circulation 2018; 137: e578\u2013622. https:\/\/doi.org\/10.1161\/cir.0000000000000560","journal-title":"Circulation"},{"key":"2520_CR17","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1161\/circulationaha.107.653584","volume":"117","author":"F Haddad","year":"2008","unstructured":"Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008; 117: 1717\u201331. https:\/\/doi.org\/10.1161\/circulationaha.107.653584","journal-title":"Circulation"},{"key":"2520_CR18","doi-asserted-by":"publisher","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","volume":"62","author":"G Simonneau","year":"2013","unstructured":"Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D34\u201341. https:\/\/doi.org\/10.1016\/j.jacc.2013.10.029","journal-title":"J Am Coll Cardiol"},{"key":"2520_CR19","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","volume":"53","author":"G Simonneau","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019; 53: 1801913. https:\/\/doi.org\/10.1183\/13993003.01913-2018","journal-title":"Eur Respir J"},{"key":"2520_CR20","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"2520_CR21","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res 2018; 27: 1785\u2013805. https:\/\/doi.org\/10.1177\/0962280216669183","journal-title":"Stat Methods Med Res"},{"key":"2520_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","volume":"45","author":"R DerSimonian","year":"2015","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials 2015; 45: 139\u201345. https:\/\/doi.org\/10.1016\/j.cct.2015.09.002","journal-title":"Contemp Clin Trials"},{"key":"2520_CR23","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1067\/mtc.2003.107","volume":"125","author":"M Hach\u00e9","year":"2003","unstructured":"Hach\u00e9 M, Denault A, B\u00e9lisle S, et al. Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery. J Thorac Cardiovasc Surg 2003; 125: 642\u20139. https:\/\/doi.org\/10.1067\/mtc.2003.107","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2520_CR24","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.ejcts.2005.09.007","volume":"28","author":"T Kramm","year":"2005","unstructured":"Kramm T, Eberle B, Guth S, Mayer E. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg 2005; 28: 882\u20138. https:\/\/doi.org\/10.1016\/j.ejcts.2005.09.007","journal-title":"Eur J Cardiothorac Surg"},{"key":"2520_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ppul.23032","volume":"50","author":"Z Xu","year":"2015","unstructured":"Xu Z, Zhu L, Liu X, Gong X, Gattrell W, Liu J. Iloprost for children with pulmonary hypertension after surgery to correct congenital heart disease. Pediatr Pulmonol 2015; 50: 588\u201395. https:\/\/doi.org\/10.1002\/ppul.23032","journal-title":"Pediatr Pulmonol"},{"key":"2520_CR26","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s12630-019-01309-8","volume":"66","author":"M Winterhalter","year":"2019","unstructured":"Winterhalter M, Rex S, Stoppe C, et al. Effect of iloprost inhalation on postoperative outcome in high-risk cardiac surgical patients: a prospective randomized-controlled multicentre trial (ILOCARD). Can J Anesth 2019; 66: 907\u201320. https:\/\/doi.org\/10.1007\/s12630-019-01309-8","journal-title":"Can J Anesth"},{"key":"2520_CR27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1053\/j.jvca.2007.10.015","volume":"22","author":"M Winterhalter","year":"2008","unstructured":"Winterhalter M, Simon A, Fischer S, et al. Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial. J Cardiothorac Vasc Anesth 2008; 22: 406\u201313. https:\/\/doi.org\/10.1053\/j.jvca.2007.10.015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2520_CR28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00392-011-0284-5","volume":"100","author":"T Loukanov","year":"2011","unstructured":"Loukanov T, Bucsenez D, Springer W, et al. Comparison of inhaled nitric oxide with aerosolized iloprost for treatment of pulmonary hypertension in children after cardiopulmonary bypass surgery. Clin Res Cardiol 2011; 100: 595\u2013602. https:\/\/doi.org\/10.1007\/s00392-011-0284-5","journal-title":"Clin Res Cardiol"},{"key":"2520_CR29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.5603\/cj.2012.0070","volume":"19","author":"A Kirbas","year":"2012","unstructured":"Kirbas A, Yalcin Y, Tanrikulu N, G\u00fcrer O, Isik O. Comparison of inhaled nitric oxide and aerosolized iloprost in pulmonary hypertension in children with congenital heart surgery. Cardiol J 2012; 19: 387\u201394. https:\/\/doi.org\/10.5603\/cj.2012.0070","journal-title":"Cardiol J"},{"key":"2520_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11748-016-0724-2","volume":"65","author":"S Abe","year":"2017","unstructured":"Abe S, Ishida K, Masuda M, et al. A prospective, randomized study of inhaled prostacyclin versus nitric oxide in patients with residual pulmonary hypertension after pulmonary endarterectomy. Gen Thorac Cardiovasc Surg 2017; 65: 153\u20139. https:\/\/doi.org\/10.1007\/s11748-016-0724-2","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2520_CR31","first-page":"38","volume":"6","author":"N Hegazy","year":"2010","unstructured":"Hegazy N. Comparison of hemodynamic effects of inhaled milrinone and inhaled prostacyclin after adult cardiac surgery. J Appl Sci Res 2010; 6: 38\u201344.","journal-title":"J Appl Sci Res"},{"key":"2520_CR32","first-page":"319","volume":"12","author":"N Yurtseven","year":"2006","unstructured":"Yurtseven N, Karaca P, Uysal G, et al. A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery. Ann Thorac Cardiovasc Surg 2006; 12: 319\u201323.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"2520_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.0886-0440.2005.200383w.x","volume":"20","author":"K Fattouch","year":"2005","unstructured":"Fattouch K, Sbraga F, Bianco G, et al. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement. J Card Surg 2005; 20: 171\u20136. https:\/\/doi.org\/10.1111\/j.0886-0440.2005.200383w.x","journal-title":"J Card Surg"},{"key":"2520_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2459\/01.jcm.0000203850.97890.fe","volume":"7","author":"K Fattouch","year":"2006","unstructured":"Fattouch K, Sbraga F, Sampognaro R, et al. Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study. J Cardiovasc Med (Hagerstown) 2006; 7: 119\u201323. https:\/\/doi.org\/10.2459\/01.jcm.0000203850.97890.fe","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2520_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1399-6576.2007.01476.x","volume":"52","author":"S Rex","year":"2008","unstructured":"Rex S, Schaelte G, Metzelder S, et al. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial. Acta Anaesthesiol Scand 2008; 52: 65\u201372. https:\/\/doi.org\/10.1111\/j.1399-6576.2007.01476.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"2520_CR36","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/j.1399-6576.2006.01139.x","volume":"50","author":"K Theodoraki","year":"2006","unstructured":"Theodoraki K, Tsiapras D, Tsourelis L, et al. Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction. Acta Anaesthesiol Scand 2006; 50: 1213\u20137. https:\/\/doi.org\/10.1111\/j.1399-6576.2006.01139.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"2520_CR37","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/bf03016884","volume":"49","author":"K Theodoraki","year":"2002","unstructured":"Theodoraki K, Rellia P, Thanopoulos A, et al. Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass. Can J Anesth 2002; 49: 963\u20137. https:\/\/doi.org\/10.1007\/bf03016884","journal-title":"Can J Anesth"},{"key":"2520_CR38","doi-asserted-by":"publisher","first-page":"R169","DOI":"10.1186\/cc9264","volume":"14","author":"LC Price","year":"2010","unstructured":"Price LC, Wort SJ, Finney SJ, Marino PS, Brett SJ. Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care 2010; 14: R169. https:\/\/doi.org\/10.1186\/cc9264","journal-title":"Crit Care"},{"key":"2520_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1213\/ane.0000000000002138","volume":"125","author":"M Elmi-Sarabi","year":"2017","unstructured":"Elmi-Sarabi M, Deschamps A, Delisle S, et al. Aerosolized vasodilators for the treatment of pulmonary hypertension in cardiac surgical patients: a systematic review and meta-analysis. Anesth Analg 2017; 125: 393\u2013402. https:\/\/doi.org\/10.1213\/ane.0000000000002138","journal-title":"Anesth Analg"},{"key":"2520_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00134-007-0831-8","volume":"34","author":"S Rex","year":"2008","unstructured":"Rex S, Missant C, Segers P, Rossaint R, Wouters PF. Epoprostenol treatment of acute pulmonary hypertension is associated with a paradoxical decrease in right ventricular contractility. Intensive Care Med 2008; 34: 179\u201389. https:\/\/doi.org\/10.1007\/s00134-007-0831-8","journal-title":"Intensive Care Med"},{"key":"2520_CR41","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1186\/cc7005","volume":"12","author":"S Rex","year":"2008","unstructured":"Rex S, Missant C, Claus P, Buhre W, Wouters PF. Effects of inhaled iloprost on right ventricular contractility, right ventriculo-vascular coupling and ventricular interdependence: a randomized placebo-controlled trial in an experimental model of acute pulmonary hypertension. Crit Care 2008; 12: R113. https:\/\/doi.org\/10.1186\/cc7005","journal-title":"Crit Care"},{"key":"2520_CR42","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/bf01712159","volume":"22","author":"O Habler","year":"1996","unstructured":"Habler O, Kleen M, Zwissler B, et al. Inhalation of prostacyclin (PGI2) for 8 hours does not produce signs of acute pulmonary toxicity in healthy lambs. Intensive Care Med 1996; 22: 426\u201333. https:\/\/doi.org\/10.1007\/bf01712159","journal-title":"Intensive Care Med"},{"key":"2520_CR43","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/s0735-1097(99)00494-5","volume":"35","author":"MM Hoeper","year":"2000","unstructured":"Hoeper MM, Olschewski H, Ghofrani HA, et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol 2000; 35: 176\u201382. https:\/\/doi.org\/10.1016\/s0735-1097(99)00494-5","journal-title":"J Am Coll Cardiol"},{"key":"2520_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1060028015608865","volume":"50","author":"K McGinn","year":"2016","unstructured":"McGinn K, Reichert M. A comparison of inhaled nitric oxide versus inhaled epoprostenol for acute pulmonary hypertension following cardiac surgery. Ann Pharmacother 2016; 50: 22\u20136. https:\/\/doi.org\/10.1177\/1060028015608865","journal-title":"Ann Pharmacother"},{"key":"2520_CR45","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1053\/j.jvca.2022.01.024","volume":"36","author":"VG Henke","year":"2022","unstructured":"Henke VG. Inhaled selective pulmonary vasodilator use after cardiac surgery: broader insights from a study describing significant changes in drug utilization and savings after implementation of a guideline favoring inhaled epoprostenol. J Cardiothorac Vasc Anesth 2022; 36: 1350\u20133. https:\/\/doi.org\/10.1053\/j.jvca.2022.01.024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2520_CR46","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1378\/chest.124.4.1294","volume":"124","author":"H Olschewski","year":"2003","unstructured":"Olschewski H, Rohde B, Behr J, et al. Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension. Chest 2003; 124: 1294\u2013304. https:\/\/doi.org\/10.1378\/chest.124.4.1294","journal-title":"Chest"},{"key":"2520_CR47","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jtcvs.2003.11.035","volume":"127","author":"CJ De Wet","year":"2004","unstructured":"De Wet CJ, Affleck DG, Jacobsohn E, et al. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg 2004; 127: 1058\u201367. https:\/\/doi.org\/10.1016\/j.jtcvs.2003.11.035","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2520_CR48","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/bmc.3123","volume":"28","author":"P Gavra","year":"2014","unstructured":"Gavra P, Nguyen AQ, Beauregard N, Denault AY, Varin F. High-performance liquid chromatography assay using ultraviolet detection for urinary quantification of milrinone concentrations in cardiac surgery patients undergoing cardiopulmonary bypass. Biomed Chromatogr 2014; 28: 1084\u20139. https:\/\/doi.org\/10.1002\/bmc.3123","journal-title":"Biomed Chromatogr"},{"key":"2520_CR49","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1038\/s41598-020-58902-x","volume":"10","author":"AQ Nguyen","year":"2020","unstructured":"Nguyen AQ, Denault AY, Th\u00e9oret Y, Perrault LP, Varin F. Inhaled milrinone in cardiac surgical patients: a pilot randomized controlled trial of jet vs. mesh nebulization. Sci Rep 2020; 10: 2069. https:\/\/doi.org\/10.1038\/s41598-020-58902-x","journal-title":"Sci Rep"},{"key":"2520_CR50","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2147\/vhrm.s3223","volume":"5","author":"S Krug","year":"2009","unstructured":"Krug S, Sablotzki A, Hammerschmidt S, Wirtz H, Seyfarth HJ. Inhaled iloprost for the control of pulmonary hypertension. Vasc Health Risk Manag 2009; 5: 465\u201374. https:\/\/doi.org\/10.2147\/vhrm.s3223","journal-title":"Vasc Health Risk Manag"},{"key":"2520_CR51","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1161\/01.cir.90.6.2780","volume":"90","author":"E Loh","year":"1994","unstructured":"Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 1994; 90: 2780\u20135. https:\/\/doi.org\/10.1161\/01.cir.90.6.2780","journal-title":"Circulation"},{"key":"2520_CR52","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1053\/j.jvca.2021.09.030","volume":"36","author":"N Diaz-Rodriguez","year":"2022","unstructured":"Diaz-Rodriguez N, Nyhan SM, Kolb TM, Steppan J. How we would treat our own pulmonary hypertension if we needed to undergo cardiac surgery. J Cardiothorac Vasc Anesth 2022; 36: 1540\u20138. https:\/\/doi.org\/10.1053\/j.jvca.2021.09.030","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2520_CR53","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1053\/j.jvca.2013.05.028","volume":"28","author":"DS Groves","year":"2014","unstructured":"Groves DS, Blum FE, Huffmyer JL, et al. Effects of early inhaled epoprostenol therapy on pulmonary artery pressure and blood loss during LVAD placement. J Cardiothorac Vasc Anesth 2014; 28: 652\u201360. https:\/\/doi.org\/10.1053\/j.jvca.2013.05.028","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2520_CR54","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1213\/ane.0000000000004793","volume":"131","author":"X Hu","year":"2020","unstructured":"Hu X, Li X, Boggett S, et al. Routine intraoperative inhaled milrinone and iloprost reduces inotrope use in patients undergoing cardiac surgery: a retrospective cohort pilot study. Anesth Analg 2020; 131: 527\u201336. https:\/\/doi.org\/10.1213\/ane.0000000000004793","journal-title":"Anesth Analg"},{"key":"2520_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/toxsci\/59.1.5","volume":"59","author":"B Weinberger","year":"2001","unstructured":"Weinberger B, Laskin DL, Heck DE, Laskin JD. The toxicology of inhaled nitric oxide. Toxicol Sci 2001; 59: 5\u201316. https:\/\/doi.org\/10.1093\/toxsci\/59.1.5","journal-title":"Toxicol Sci"},{"key":"2520_CR56","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1213\/ane.0000000000006192","volume":"136","author":"M Elmi-Sarabi","year":"2023","unstructured":"Elmi-Sarabi M, Jarry S, Couture EJ, et al. Pulmonary vasodilator response of combined inhaled epoprostenol and inhaled milrinone in cardiac surgical patients. Anesth Analg 2023; 136: 282\u201394. https:\/\/doi.org\/10.1213\/ane.0000000000006192","journal-title":"Anesth Analg"},{"key":"2520_CR57","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539\u201358. https:\/\/doi.org\/10.1002\/sim.1186","journal-title":"Stat Med"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-023-02520-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12630-023-02520-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-023-02520-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:02:08Z","timestamp":1719532928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12630-023-02520-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2520"],"URL":"https:\/\/doi.org\/10.1007\/s12630-023-02520-4","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]},"assertion":[{"value":"11 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}